BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 2, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 17, 2002
View Archived Issues
Pharmacyclics: New Phase III Sharpens Cancer Drug’s Focus
Pharmacyclics Inc. is planning a new Phase III trial of its cancer cell disrupter, Xcytrin, in the sector of patients for whom the drug seems to do the most good those with lung cancer that has metastasized to the brain. (BioWorld Today)
Read More
Bacillus subtilis Pinch Hits For B. anthracis To Make Antibodies From Spore Targets For Vaccine
Read More
Hatch Expects Election-Year Debates On Health Care Bills
Read More
Syntonix Series B Gets $35.8M For Large-Molecule Delivery
Read More
Other News To Note
Read More
Correction
Read More
Plexxikon Raises $27M Privately For Scaffold Discovery System
Read More